A synthetic gene of Top7 was purchased from Eurofins genomics (eurofinsgenomics.jp; accessed on 20 October 2021) and subcloned into a pET28 vector. Expression vectors of the Top7 variants were constructed by a PCR-based mutagenesis using a
PrimeSTAR DNA polymerase (Takara Bio Inc., Shiga, Japan). All protein samples were expressed by
E. coli BL21(DE3) strain using Studier’s autoinduction medium [13 (
link)]. After one-step purification with
Ni-NTA agarose resin (FUJIFILM Wako Pure Chemical Corporation, Tokyo, Japan), the N-terminal hexahistidine tag was removed by thrombin cleavage. The protein samples were re-applied to the Ni-NTA column to remove the cleaved tag and uncleaved protein.
Analytical SEC was performed using a
Superdex200 10/300 column (GE Healthcare, Chicago, IL, USA) equilibrated with a 50 mM phosphate pH 7.0, 150 mM NaCl buffer by monitoring 280 nm absorbance.
CD spectra were measured using a CD spectrometer J-820 (JASCO, Tokyo, Japan) with 10 μM protein samples in a 50 mM phosphate pH 7.0, 150 mM NaCl buffer, and 25 °C. A 1 mm quartz cell was used.
Ito Y., Araki T., Shiga S., Konno H, & Makabe K. (2022). Surface Engineering of Top7 to Facilitate Structure Determination. International Journal of Molecular Sciences, 23(2), 701.